These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27730066)

  • 1. Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting.
    Kaur P; Mahendru S; Mithal A
    Indian J Endocrinol Metab; 2016; 20(5):595-599. PubMed ID: 27730066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effectiveness of Liraglutide in Association with Patients' Baseline Characteristics in Real-Life Setting in Croatia: An Observational, Retrospective, Multicenter Study.
    Berkovic MC; Bilic-Curcic I; Herman Mahecic D; Gradiser M; Grgurevic M; Bozek T
    Diabetes Ther; 2017 Dec; 8(6):1297-1308. PubMed ID: 29076038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight and glycemic control in Japanese type 2 diabetes: an observational study.
    Inoue K; Maeda N; Fujishima Y; Fukuda S; Nagao H; Yamaoka M; Hirata A; Nishizawa H; Funahashi T; Shimomura I
    Diabetol Metab Syndr; 2014; 6(1):95. PubMed ID: 25237400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with Liraglutide in 196 patients with type 2 diabetes from a tertiary care center in India.
    Kaur P; Mishra SK; Mithal A; Saxena M; Makkar A; Sharma P
    Indian J Endocrinol Metab; 2014 Jan; 18(1):77-82. PubMed ID: 24701434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide therapy beyond glycemic control: an observational study in Indian patients with type 2 diabetes in real world setting.
    Kesavadev J; Shankar A; Krishnan G; Jothydev S
    Int J Gen Med; 2012; 5():317-22. PubMed ID: 22536087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Genetic Predictors of Glycemic Control and Weight Loss Response to Liraglutide in Patients with Type 2 Diabetes.
    Kyriakidou A; Kyriazou AV; Koufakis T; Vasilopoulos Y; Grammatiki M; Tsekmekidou X; Avramidis I; Baltagiannis S; Goulis DG; Zebekakis P; Kotsa K
    J Pers Med; 2022 Mar; 12(3):. PubMed ID: 35330424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics.
    García-Pérez LE; Boye KS; Rosilio M; Jung H; Heitmann E; Norrbacka K; Federici MO; Gentilella R; Guerci B; Giorgino F; Aigner U; Sapin H
    Diabetes Ther; 2021 Jul; 12(7):1929-1946. PubMed ID: 34097244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide - Indian Experience.
    Anirban M; Soumyabrata RC; Debmalya S; Bhattacharjee K
    Indian J Endocrinol Metab; 2018; 22(6):818-826. PubMed ID: 30766825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Liraglutide and Lixisenatide in the Treatment of Type 2 Diabetes: Real-World Evidence from The Health Improvement Network (THIN) Database in the United Kingdom.
    Feher M; Vega-Hernandez G; Mocevic E; Buysse B; Myland M; Power GS; Nystrup Husemoen LL; Kim J; Witte DR
    Diabetes Ther; 2017 Apr; 8(2):417-431. PubMed ID: 28281244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review.
    Ostawal A; Mocevic E; Kragh N; Xu W
    Diabetes Ther; 2016 Sep; 7(3):411-38. PubMed ID: 27350545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients.
    Fadini GP; Simioni N; Frison V; Dal Pos M; Bettio M; Rocchini P; Avogaro A
    Acta Diabetol; 2013 Dec; 50(6):943-9. PubMed ID: 23754673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Database Study of Liraglutide Persistence Associated with Glycemic and Body Weight Control in Patients with Type 2 Diabetes.
    Melzer-Cohen C; Chodick G; Husemoen LLN; Rhee N; Shalev V; Karasik A
    Diabetes Ther; 2019 Apr; 10(2):683-696. PubMed ID: 30815829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain.
    Gomez-Peralta F; Lecube A; Fernández-Mariño A; Alonso Troncoso I; Morales C; Morales-Pérez FM; Guler I; Cadarso-Suárez C
    Diabet Med; 2018 Nov; 35(11):1605-1612. PubMed ID: 29943854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liraglutide as add-on therapy to insulin in type 2 diabetes mellitus: a retrospective, observational study from a daily clinical practice setting in Switzerland.
    Lipowsky C; Sze L; Krull I; Brändle M
    Diabetes Ther; 2015 Mar; 6(1):41-7. PubMed ID: 25576400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective audit of type 2 diabetes patients prescribed liraglutide in real-life clinical practice.
    Mulligan CM; Harper R; Harding J; McIlwaine W; Petruckevitch A; McLaughlin DM
    Diabetes Ther; 2013 Jun; 4(1):147-51. PubMed ID: 23715814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liraglutide in the treatment of Type 2 diabetes: clinical data and practical considerations for its use.
    Ampudia-Blasco FJ; Gómez CC; Claramunt XC; Alegría JG; Gimeno EJ; Bravo JJM; Raya PM; Pérez JN; Domingo MP
    Expert Rev Endocrinol Metab; 2010 Nov; 5(6):799-807. PubMed ID: 30780828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with Type 2 diabetes: a prospective study.
    Díaz-Soto G; de Luis DA; Conde-Vicente R; Izaola-Jauregui O; Ramos C; Romero E
    Diabetes Res Clin Pract; 2014 Apr; 104(1):92-6. PubMed ID: 24530118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Effectiveness of Liraglutide vs Sitagliptin on Glycemic Control and Body Weight in Patients with Type 2 Diabetes: A Retrospective Assessment in Sweden.
    Lind M; Matsson PO; Linder R; Svenningsson I; Jørgensen L; Ploug UJ; Gydesen H; Dorkhan M; Larsen S; Johansson G
    Diabetes Ther; 2016 Jun; 7(2):321-33. PubMed ID: 27216947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liraglutide Effect on Weight, Glycated Hemoglobin, and Blood Pressure: A Single-Center Experience in the Eastern Province of Saudi Arabia.
    Alsafwani DM; Alotaibi HN; Alzaid JA; Alghamdi A; Almakhaita HM
    Cureus; 2022 Mar; 14(3):e23554. PubMed ID: 35371841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose liraglutide in Indian patients with type 2 diabetes in the real world setting.
    Sanyal D; Majumdar A
    Indian J Endocrinol Metab; 2013 Oct; 17(Suppl 1):S301-3. PubMed ID: 24251194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.